217 related articles for article (PubMed ID: 18239607)
1. IL4 gene delivery to the CNS recruits regulatory T cells and induces clinical recovery in mouse models of multiple sclerosis.
Butti E; Bergami A; Recchia A; Brambilla E; Del Carro U; Amadio S; Cattalini A; Esposito M; Stornaiuolo A; Comi G; Pluchino S; Mavilio F; Martino G; Furlan R
Gene Ther; 2008 Apr; 15(7):504-15. PubMed ID: 18239607
[TBL] [Abstract][Full Text] [Related]
2. Absence of an intrathecal immune reaction to a helper-dependent adenoviral vector delivered into the cerebrospinal fluid of non-human primates.
Butti E; Bergami A; Recchia A; Brambilla E; Franciotta D; Cattalini A; Stornaiuolo A; Lachapelle F; Comi G; Mavilio F; Martino G; Furlan R
Gene Ther; 2008 Feb; 15(3):233-8. PubMed ID: 17960158
[TBL] [Abstract][Full Text] [Related]
3. CCR6 regulates EAE pathogenesis by controlling regulatory CD4+ T-cell recruitment to target tissues.
Villares R; Cadenas V; Lozano M; Almonacid L; Zaballos A; Martínez-A C; Varona R
Eur J Immunol; 2009 Jun; 39(6):1671-81. PubMed ID: 19499521
[TBL] [Abstract][Full Text] [Related]
4. IL-21 modulates CD4+ CD25+ regulatory T-cell homeostasis in experimental autoimmune encephalomyelitis.
Piao WH; Jee YH; Liu RL; Coons SW; Kala M; Collins M; Young DA; Campagnolo DI; Vollmer TL; Bai XF; La Cava A; Shi FD
Scand J Immunol; 2008 Jan; 67(1):37-46. PubMed ID: 18052963
[TBL] [Abstract][Full Text] [Related]
5. TREM2-transduced myeloid precursors mediate nervous tissue debris clearance and facilitate recovery in an animal model of multiple sclerosis.
Takahashi K; Prinz M; Stagi M; Chechneva O; Neumann H
PLoS Med; 2007 Apr; 4(4):e124. PubMed ID: 17425404
[TBL] [Abstract][Full Text] [Related]
6. Expression of interleukin-4 but not of interleukin-10 from a replicative herpes simplex virus type 1 viral vector precludes experimental allergic encephalomyelitis.
Broberg E; Setälä N; Röyttä M; Salmi A; Erälinna JP; He B; Roizman B; Hukkanen V
Gene Ther; 2001 May; 8(10):769-77. PubMed ID: 11420640
[TBL] [Abstract][Full Text] [Related]
7. IL-4 is the key regulator in herpes simplex virus-based gene therapy of BALB/c experimental autoimmune encephalomyelitis.
Broberg EK; Salmi AA; Hukkanen V
Neurosci Lett; 2004 Jul; 364(3):173-8. PubMed ID: 15196670
[TBL] [Abstract][Full Text] [Related]
8. Immune responses against tetracycline-dependent transactivators affect long-term expression of mouse erythropoietin delivered by a helper-dependent adenoviral vector.
Lena AM; Giannetti P; Sporeno E; Ciliberto G; Savino R
J Gene Med; 2005 Aug; 7(8):1086-96. PubMed ID: 15772935
[TBL] [Abstract][Full Text] [Related]
9. Low-density lipoprotein receptor gene therapy using helper-dependent adenovirus produces long-term protection against atherosclerosis in a mouse model of familial hypercholesterolemia.
Nomura S; Merched A; Nour E; Dieker C; Oka K; Chan L
Gene Ther; 2004 Oct; 11(20):1540-8. PubMed ID: 15269711
[TBL] [Abstract][Full Text] [Related]
10. A potential role for estrogen in experimental autoimmune encephalomyelitis and multiple sclerosis.
Offner H; Polanczyk M
Ann N Y Acad Sci; 2006 Nov; 1089():343-72. PubMed ID: 17261780
[TBL] [Abstract][Full Text] [Related]
11. Viral-mediated delivery of the late-infantile neuronal ceroid lipofuscinosis gene, TPP-I to the mouse central nervous system.
Haskell RE; Hughes SM; Chiorini JA; Alisky JM; Davidson BL
Gene Ther; 2003 Jan; 10(1):34-42. PubMed ID: 12525835
[TBL] [Abstract][Full Text] [Related]
12. T-cell trafficking competence is required for CNS invasion.
Lees JR; Archambault AS; Russell JH
J Neuroimmunol; 2006 Aug; 177(1-2):1-10. PubMed ID: 16822552
[TBL] [Abstract][Full Text] [Related]
13. 1,25-dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by inhibiting chemokine synthesis and monocyte trafficking.
Pedersen LB; Nashold FE; Spach KM; Hayes CE
J Neurosci Res; 2007 Aug; 85(11):2480-90. PubMed ID: 17600374
[TBL] [Abstract][Full Text] [Related]
14. Specific central nervous system recruitment of HLA-G(+) regulatory T cells in multiple sclerosis.
Huang YH; Zozulya AL; Weidenfeller C; Metz I; Buck D; Toyka KV; Brück W; Wiendl H
Ann Neurol; 2009 Aug; 66(2):171-83. PubMed ID: 19705413
[TBL] [Abstract][Full Text] [Related]
15. CXCL12 (SDF-1alpha) suppresses ongoing experimental autoimmune encephalomyelitis by selecting antigen-specific regulatory T cells.
Meiron M; Zohar Y; Anunu R; Wildbaum G; Karin N
J Exp Med; 2008 Oct; 205(11):2643-55. PubMed ID: 18852294
[TBL] [Abstract][Full Text] [Related]
16. Adenoviral delivery of soluble VEGF receptor 1 (sFlt-1) inhibits experimental autoimmune encephalomyelitis in dark Agouti (DA) rats.
Zhu CS; Hu XQ; Xiong ZJ; Lu ZQ; Zhou GY; Wang DJ
Life Sci; 2008 Sep; 83(11-12):404-12. PubMed ID: 18721816
[TBL] [Abstract][Full Text] [Related]
17. Widespread gene transduction to the central nervous system by adenovirus in utero: implication for prenatal gene therapy to brain involvement of lysosomal storage disease.
Shen JS; Meng XL; Maeda H; Ohashi T; Eto Y
J Gene Med; 2004 Nov; 6(11):1206-15. PubMed ID: 15459963
[TBL] [Abstract][Full Text] [Related]
18. The murine gammaherpesvirus-68 chemokine-binding protein M3 inhibits experimental autoimmune encephalomyelitis.
Millward JM; Holst PJ; Høgh-Petersen M; Thomsen AR; Christensen JP; Owens T
J Neuroimmunol; 2010 Jul; 224(1-2):45-50. PubMed ID: 20537410
[TBL] [Abstract][Full Text] [Related]
19. The role of regulatory T cells in multiple sclerosis.
Zozulya AL; Wiendl H
Nat Clin Pract Neurol; 2008 Jul; 4(7):384-98. PubMed ID: 18578001
[TBL] [Abstract][Full Text] [Related]
20. Gene therapy in nonhuman primate models of human autoimmune disease.
t'Hart BA; Vervoordeldonk M; Heeney JL; Tak PP
Gene Ther; 2003 May; 10(10):890-901. PubMed ID: 12732874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
